Point72 Hong Kong LTD Collegium Pharmaceutical, Inc Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$17.2 - $22.5 $5,504 - $7,200	-320 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $33,810 - $41,248	-1,932 Reduced 85.79%	320 $6,000
Q3 2021 Nov 15, 2021	BUY	$17.75 - $25.39 $39,973 - $57,178	2,252 New	2,252 $44,000
Q3 2020 Nov 16, 2020	SELL	$15.78 - $20.82 $10,903 - $14,386	-691 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$15.49 - $23.51 $10,703 - $16,245	691 New	691 $12,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $21,016 - $32,831	-1,979 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $26,874 - $37,046	1,979 New	1,979 $30,000
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $41,354 - $55,064	-2,798 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $35,810 - $61,454	2,529 Added 940.15%	2,798 $41,000
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $5,861 - $7,610	269 New	269 $6,000

249

36.2M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.